Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Stanley Davis

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Objects

Microspheres

Concepts & Ideas

Chemicals & Drugs

Living Beings

Devices

Drug Delivery Systems

Procedures

Intranasal Administration

Physiology

Gastrointestinal Transit

Phenomena

Surface Properties

Occupations

Pharmaceutical Chemistry

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
69
Illum, Lisbeth
21
Wilding, Ian
18
Coombes, A G A
16
Garnett, Martin
14
Stolnik, Snjezana
12
Sparrow, Robert
11
Moghimi, SM
11
Davies, Martyn
9
Lavelle, Ed
8
Fisher, AN
8
Jabbal-Gill, Inderjit
7
Hinchcliffe, Michael
7
Barrett, David
6
Melia, Colin
6
Shaw, Nicholas

Sign-in to see all Coauthors

Publications

TOP 3
Charlton Stuart T; Whetstone Joanne; Fayinka Susan T; Read Kevin D; Illum Lisbeth; Davis Stanley S
Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.
Charlton Stuart T; Davis Stanley S; Illum Lisbeth
Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system.
Charlton S T; Davis S S; Illum L
Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Stanley Davis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Charlton Stuart T; Whetstone Joanne; Fayinka Susan T; Read Kevin D; Illum Lisbeth; Davis Stanley S
Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.
Pharmaceutical research 2008;25(7):1531-43.
2007: Charlton Stuart T; Davis Stanley S; Illum Lisbeth
Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system.
Journal of drug targeting 2007;15(5):370-7.
2007: Charlton S T; Davis S S; Illum L
Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.
International journal of pharmaceutics 2007;338(1-2):94-103.
2007: Charlton S T; Davis S S; Illum L
Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
Journal of controlled release : official journal of the Controlled Release Society 2007;118(2):225-34.
2007: Charlton S; Jones N S; Davis S S; Illum L
Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;30(3-4):295-302.
2006: Davis Stanley S
The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery.
Vaccine 2006;24 Suppl 2():S2-7-10.
2005: Stolnik S; Heald C R; Garnett M G; Illum L; Davis S S
Differences in the adsorption behaviour of poly(ethylene oxide) copolymers onto model polystyrene nanoparticles assessed by isothermal titration microcalorimetry correspond to the biological differences.
Journal of drug targeting 2005;13(8-9):449-58.
2005: Davis Stanley S
Formulation strategies for absorption windows.
Drug discovery today 2005;10(4):249-57.
2004: Robinson Mark A; Charlton Stuart T; Garnier Philippe; Wang Xiang-tao; Davis Stanley S; Perkins Alan C; Frier Malcolm; Duncan Ruth; Savage Tony J; Wyatt David A; Watson Susan A; Davis Benjamin G
LEAPT: lectin-directed enzyme-activated prodrug therapy.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(40):14527-32.
2004: Han Jihong; Davis Stanley S; Papandreou Catherine; Melia Colin D; Washington Clive
Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stability.
Pharmaceutical research 2004;21(9):1573-80.
2004: Davis S S
Coming of age of lipid-based drug delivery systems.
Advanced drug delivery reviews 2004;56(9):1241-2.
2003: Illum L; Hinchcliffe M; Davis S S
The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.
Pharmaceutical research 2003;20(9):1474-84.
2003: Iqbal M; Lin W; Jabbal-Gill I; Davis S S; Steward M W; Illum L
Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.
Vaccine 2003;21(13-14):1478-85.
2003: Davis Stanley S; Illum Lisbeth
Absorption enhancers for nasal drug delivery.
Clinical pharmacokinetics 2003;42(13):1107-28.
2002: Davis Stanley S
Parenteral polymers.
Drug discovery today 2002;7(23):1159-61.
2002: Dobson Clair L; Davis Stanley S; Chauhan Sushil; Sparrow Robert A; Wilding Ian R
The effect of ileal brake activators on the oral bioavailability of atenolol in man.
International journal of pharmaceutics 2002;248(1-2):61-70.
2002: Rackstraw Benjamin J; Stolnik Snjezana; Davis Stanley S; Bignotti Fabio; Garnett Martin C
Development of multicomponent DNA delivery systems based upon poly(amidoamine)-PEG co-polymers.
Biochimica et biophysica acta 2002;1576(3):269-86.
2002: Illum L; Watts P; Fisher A N; Hinchcliffe M; Norbury H; Jabbal-Gill I; Nankervis R; Davis S S
Intranasal delivery of morphine.
The Journal of pharmacology and experimental therapeutics 2002;301(1):391-400.
2002: Cheng Yu Hui; Watts P; Hinchcliffe M; Hotchkiss R; Nankervis R; Faraj N F; Smith A; Davis S S; Illum L
Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.
Journal of controlled release : official journal of the Controlled Release Society 2002;79(1-3):243-54.
2001: Stolnik S; Daudali B; Arien A; Whetstone J; Heald C R; Garnett M C; Davis S S; Illum L
The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers.
Biochimica et biophysica acta 2001;1514(2):261-79.
2001: Jabbal-Gill I; Lin W; Kistner O; Davis S S; Illum L
Polymeric lamellar substrate particles for intranasal vaccination.
Advanced drug delivery reviews 2001;51(1-3):97-111.
2001: Illum L; Jabbal-Gill I; Hinchcliffe M; Fisher A N; Davis S S
Chitosan as a novel nasal delivery system for vaccines.
Advanced drug delivery reviews 2001;51(1-3):81-96.
2001: Davis S S
Nasal vaccines.
Advanced drug delivery reviews 2001;51(1-3):21-42.
2001: Govender T; Stolnik S; Xiong C; Zhang S; Illum L; Davis S S
Drug-polyionic block copolymer interactions for micelle formation: physicochemical characterisation.
Journal of controlled release : official journal of the Controlled Release Society 2001;75(3):249-58.
2001: Illum L; Fisher A N; Jabbal-Gill I; Davis S S
Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.
International journal of pharmaceutics 2001;222(1):109-19.
2001: Illum L; Church A E; Butterworth M D; Arien A; Whetstone J; Davis S S
Development of systems for targeting the regional lymph nodes for diagnostic imaging: in vivo behaviour of colloidal PEG-coated magnetite nanospheres in the rat following interstitial administration.
Pharmaceutical research 2001;18(5):640-5.
2001: Soane R J; Hinchcliffe M; Davis S S; Illum L
Clearance characteristics of chitosan based formulations in the sheep nasal cavity.
International journal of pharmaceutics 2001;217(1-2):183-91.
2001: Hill I R; Garnett M C; Bignotti F; Davis S S
Determination of protection from serum nuclease activity by DNA-polyelectrolyte complexes using an electrophoretic method.
Analytical biochemistry 2001;291(1):62-8.
2001: Han J; Davis S S; Washington C
Physical properties and stability of two emulsion formulations of propofol.
International journal of pharmaceutics 2001;215(1-2):207-20.
2001: Lin W; Garnett M C; Davis S S; Schacht E; Ferruti P; Illum L
Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 2001;71(1):117-26.
2001: Soane R J; Carney A S; Jones N S; Frier M; Perkins A C; Davis S S; Illum L
The effect of the nasal cycle on mucociliary clearance.
Clinical otolaryngology and allied sciences 2001;26(1):9-15.
2001: Redhead H M; Davis S S; Illum L
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.
Journal of controlled release : official journal of the Controlled Release Society 2001;70(3):353-63.
2001: Davis S S; Illum L; Hinchcliffe M
Gastrointestinal transit of dosage forms in the pig.
The Journal of pharmacy and pharmacology 2001;53(1):33-9.
2001: Stolnik S; Heald C R; Neal J; Garnett M C; Davis S S; Illum L; Purkis S C; Barlow R J; Gellert P R
Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance.
Journal of drug targeting 2001;9(5):361-78.
2001: Brooking J; Davis S S; Illum L
Transport of nanoparticles across the rat nasal mucosa.
Journal of drug targeting 2001;9(4):267-79.
2000: McNeela E A; O'Connor D; Jabbal-Gill I; Illum L; Davis S S; Pizza M; Peppoloni S; Rappuoli R; Mills K H
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery.
Vaccine 2000;19(9-10):1188-98.
2000: Jones N A; Hill I R; Stolnik S; Bignotti F; Davis S S; Garnett M C
Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer-DNA complexes for gene delivery.
Biochimica et biophysica acta 2000;1517(1):1-18.
2000: Govender T; Riley T; Ehtezazi T; Garnett M C; Stolnik S; Illum L; Davis S S
Defining the drug incorporation properties of PLA-PEG nanoparticles.
International journal of pharmaceutics 2000;199(1):95-110.
2000: Dobson C L; Davis S S; Chauhan S; Sparrow R A; Wilding I R
Does the site of intestinal delivery of oleic acid alter the ileal brake response?
International journal of pharmaceutics 2000;195(1-2):63-70.
2000: Cheng Y H; Illum L; Davis S S
Schizophrenia and drug delivery systems.
Journal of drug targeting 2000;8(2):107-17.
1999: Lin W; Garnett M C; Schacht E; Davis S S; Illum L
Preparation and in vitro characterization of HSA-mPEG nanoparticles.
International journal of pharmaceutics 1999;189(2):161-70.
1999: Jabbal-Gill I; Lin W; Jenkins P; Watts P; Jimenez M; Illum L; Davis S S; Wood J M; Major D; Minor P D; Li X; Lavelle E C; Coombes A G
Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines.
Vaccine 1999;18(3-4):238-50.
1999: He P; Davis S S; Illum L
Chitosan microspheres prepared by spray drying.
International journal of pharmaceutics 1999;187(1):53-65.
1999: Govender T; Ehtezazi T; Stolnik S; Illum L; Davis S S
Complex formation between the anionic polymer (PAA) and a cationic drug (procaine HCI): characterization by microcalorimetric studies.
Pharmaceutical research 1999;16(7):1125-31.
1999: Delgado A; Lavelle E C; Hartshorne M; Davis S S
PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
Vaccine 1999;17(22):2927-38.
1999: Scholes P D; Coombes A G; Illum L; Davis S S; Watts J F; Ustariz C; Vert M; Davies M C
Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.
Journal of controlled release : official journal of the Controlled Release Society 1999;59(3):261-78.
1999: Coombes A G; Lavelle E C; Davis S S
Biodegradable lamellar particles of poly(lactide) induce sustained immune responses to a single dose of adsorbed protein.
Vaccine 1999;17(19):2410-22.
1999: He P; Davis S S; Illum L
Sustained release chitosan microspheres prepared by novel spray drying methods.
Journal of microencapsulation 1999;16(3):343-55.
1999: Hill I R; Garnett M C; Bignotti F; Davis S S
In vitro cytotoxicity of poly(amidoamine)s: relevance to DNA delivery.
Biochimica et biophysica acta 1999;1427(2):161-74.
1999: Cortesi R; Esposito E; Osti M; Squarzoni G; Menegatti E; Davis S S; Nastruzzi C
Dextran cross-linked gelatin microspheres as a drug delivery system.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(2):153-60.
1999: Soane R J; Frier M; Perkins A C; Jones N S; Davis S S; Illum L
Evaluation of the clearance characteristics of bioadhesive systems in humans.
International journal of pharmaceutics 1999;178(1):55-65.
1999: Lavelle E C; Yeh M K; Coombes A G; Davis S S
The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Vaccine 1999;17(6):512-29.
1999: Govender T; Stolnik S; Garnett M C; Illum L; Davis S S
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
Journal of controlled release : official journal of the Controlled Release Society 1999;57(2):171-85.
1999: Dobson C L; Davis S S; Chauhan S; Sparrow R A; Wilding I R
The effect of oleic acid on the human ileal brake and its implications for small intestinal transit of tablet formulations.
Pharmaceutical research 1999;16(1):92-6.
1998: Jabbal-Gill I; Fisher A N; Rappuoli R; Davis S S; Illum L
Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
Vaccine 1998;16(20):2039-46.
1998: Cheng Y H; Illum L; Davis S S
A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol.
Journal of controlled release : official journal of the Controlled Release Society 1998;55(2-3):203-12.
1998: Neal J C; Stolnik S; Schacht E; Kenawy E R; Garnett M C; Davis S S; Illum L
In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres.
Journal of pharmaceutical sciences 1998;87(10):1242-8.
1998: Cortesi R; Nastruzzi C; Davis S S
Sugar cross-linked gelatin for controlled release: microspheres and disks.
Biomaterials 1998;19(18):1641-9.
1998: Coombes A G; Major D; Wood J M; Hockley D J; Minor P D; Davis S S
Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines.
Biomaterials 1998;19(11-12):1073-81.
1998: Dobson C L; Hinchcliffe M; Davis S S; Chauhan S; Wilding I R
Is the pig a good animal model for studying the human ileal brake?
Journal of pharmaceutical sciences 1998;87(5):565-8.
1998: Hawley A E; Illum L; Davis S S
The effect of lymphatic oedema on the uptake of colloids to the lymph nodes.
Biopharmaceutics & drug disposition 1998;19(3):193-7.
1998: Coombes A G; Yeh M K; Lavelle E C; Davis S S
The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method.
Journal of controlled release : official journal of the Controlled Release Society 1998;52(3):311-20.
1998: Neal J C; Stolnik S; Garnett M C; Davis S S; Illum L
Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.
Pharmaceutical research 1998;15(2):318-24.
1998: Gill I J; Fisher A N; Farraj N; Pitt C G; Davis S S; Illum L
Intranasal absorption of granulocyte-colony stimulating factor (G-CSF) from powder formulations, in sheep.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1998;6(1):1-10.
1998: Takahata H; Lavelle E C; Coombes A G; Davis S S
The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids.
Journal of controlled release : official journal of the Controlled Release Society 1998;50(1-3):237-46.
1997: Rafati H; Lavelle E C; Coombes A G; Stolnik S; Holland J; Davis S S
The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.
Vaccine 1997;15(17-18):1888-97.
1997: Armstrong T I; Moghimi S M; Davis S S; Illum L
Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.
Pharmaceutical research 1997;14(11):1629-33.
1997: Coombes A G; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies M C; Illum L; Davis S S
Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
Biomaterials 1997;18(17):1153-61.
1997: Vandorpe J; Schacht E; Dunn S; Hawley A; Stolnik S; Davis S S; Garnett M C; Davies M C; Illum L
Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
Biomaterials 1997;18(17):1147-52.
1997: Brown J; Hooper G; Kenyon C J; Haines S; Burt J; Humphries J M; Newman S P; Davis S S; Sparrow R A; Wilding I R
Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy.
Pharmaceutical research 1997;14(8):1073-8.
1997: Hawley A E; Illum L; Davis S S
Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake.
Pharmaceutical research 1997;14(5):657-61.
1997: Lin W; Garnett M C; Davies M C; Bignotti F; Ferruti P; Davis S S; Illum L
Preparation of surface-modified albumin nanospheres.
Biomaterials 1997;18(7):559-65.
1997: Hawley A E; Illum L; Davis S S
Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers.
FEBS letters 1997;400(3):319-23.
1996: Thomas N W; Jenkins P G; Howard K A; Smith M W; Lavelle E C; Holland J; Davis S S
Particle uptake and translocation across epithelial membranes.
Journal of anatomy 1996;189 ( Pt 3)():487-90.
1996: Yeh M K; Davis S S; Coombes A G
Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers.
Pharmaceutical research 1996;13(11):1693-8.
1996: Illum L; Davis S S; Pawula M; Fisher A N; Barrett D A; Farraj N F; Shaw P N
Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic study.
Biopharmaceutics & drug disposition 1996;17(8):717-24.
1996: Coombes A G; Lavelle E C; Jenkins P G; Davis S S
Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen.
Vaccine 1996;14(15):1429-38.
1996: Avdeef A; Barrett D A; Shaw P N; Knaggs R D; Davis S S
Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates.
Journal of medicinal chemistry 1996;39(22):4377-81.
1996: Lance M R; Washington C; Davis S S
Evidence for the formation of amphotericin B-phospholipid complexes in Langmuir monolayers.
Pharmaceutical research 1996;13(7):1008-14.
1995: Adkin D A; Davis S S; Sparrow R A; Huckle P D; Wilding I R
The effect of mannitol on the oral bioavailability of cimetidine.
Journal of pharmaceutical sciences 1995;84(12):1405-9.
1995: Vordermeier H M; Coombes A G; Jenkins P; McGee J P; O'Hagan D T; Davis S S; Singh M
Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles.
Vaccine 1995;13(16):1576-82.
1995: Lance M R; Washington C; Davis S S
Structure and toxicity of amphotericin B/triglyceride emulsion formulations.
The Journal of antimicrobial chemotherapy 1995;36(1):119-28.
1995: Harper G R; Davis S S; Davies M C; Norman M E; Tadros T F; Taylor D C; Irving M P; Waters J A; Watts J F
Influence of surface coverage with poly(ethylene oxide) on attachment of sterically stabilized microspheres to rat Kupffer cells in vitro.
Biomaterials 1995;16(6):427-39.
1995: Adkin D A; Davis S S; Sparrow R A; Huckle P D; Phillips A J; Wilding I R
The effects of pharmaceutical excipients on small intestinal transit.
British journal of clinical pharmacology 1995;39(4):381-7.
1995: Adkin D A; Davis S S; Sparrow R A; Huckle P D; Phillips A J; Wilding I R
The effect of different concentrations of mannitol in solution on small intestinal transit: implications for drug absorption.
Pharmaceutical research 1995;12(3):393-6.
1995: Jenkins P G; Coombes A G; Yeh M K; Thomas N W; Davis S S
Aspects of the design and delivery of microparticles for vaccine applications.
Journal of drug targeting 1995;3(1):79-81.
1994: Stolnik S; Dunn S E; Garnett M C; Davies M C; Coombes A G; Taylor D C; Irving M P; Purkiss S C; Tadros T F; Davis S S
Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers.
Pharmaceutical research 1994;11(12):1800-8.
1994: Lin W; Coombes A G; Garnett M C; Davies M C; Schacht E; Davis S S; Illum L
Preparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agent.
Pharmaceutical research 1994;11(11):1588-92.
1994: Awang M B; Hardy J G; Davis S S; Pimm M V; Parry S J; Wilding I R
Evaluation of 153Sm-diethylenetriaminepentaacetic acid for radiolabelling of pharmaceutical dosage forms by neutron activation.
Nuclear medicine and biology 1994;21(7):905-9.
1994: Illum L; Farraj N F; Davis S S
Chitosan as a novel nasal delivery system for peptide drugs.
Pharmaceutical research 1994;11(8):1186-9.
1994: Critchley H; Davis S S; Farraj N F; Illum L
Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system.
The Journal of pharmacy and pharmacology 1994;46(8):651-6.
1994: Coombes A G; Scholes P D; Davies M C; Illum L; Davis S S
Resorbable polymeric microspheres for drug delivery--production and simultaneous surface modification using PEO-PPO surfactants.
Biomaterials 1994;15(9):673-80.
1994: Dunn S E; Brindley A; Davis S S; Davies M C; Illum L
Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.
Pharmaceutical research 1994;11(7):1016-22.
1994: Chen C Q; Lin W; Coombes A G; Davis S S; Illum L
Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method.
Journal of microencapsulation 1994;11(4):395-407.
1994: Wilding I R; Davis S S; O'Hagan D T
Optimizing gastrointestinal delivery of drugs.
Baillière's clinical gastroenterology 1994;8(2):255-70.
1994: Moghimi S M; Hawley A E; Christy N M; Gray T; Illum L; Davis S S
Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes.
FEBS letters 1994;344(1):25-30.
1994: Wilding I R; Davis S S; O'Hagan D T
Targeting of drugs and vaccines to the gut.
Pharmacology & therapeutics 1994;62(1-2):97-124.
1994: Moghimi S M; Davis S S
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection.
Critical reviews in therapeutic drug carrier systems 1994;11(1):31-59.
1993: Moghimi S M; Hedeman H; Christy N M; Illum L; Davis S S
Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats.
Journal of leukocyte biology 1993;54(6):513-7.
1993: Moghimi S M; Muir I S; Illum L; Davis S S; Kolb-Bachofen V
Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.
Biochimica et biophysica acta 1993;1179(2):157-65.
1993: Barrett D A; Simpson J; Rutter N; Kurihara-Bergstrom T; Shaw P N; Davis S S
The pharmacokinetics and physiological effects of buprenorphine infusion in premature neonates.
British journal of clinical pharmacology 1993;36(3):215-9.
1993: Moghimi S M; Hedeman H; Muir I S; Illum L; Davis S S
An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen.
Biochimica et biophysica acta 1993;1157(3):233-40.
1993: Sidhu B K; Washington C; Davis S S; Purewal T S
Rheology of model aerosol suspensions.
The Journal of pharmacy and pharmacology 1993;45(7):597-600.
1993: Price J M; Davis S S; Wilding I R
Characterization of colonic transit of nondisintegrating tablets in healthy subjects.
Digestive diseases and sciences 1993;38(6):1015-21.
1993: Moghimi S M; Hedeman H; Illum L; Davis S S
Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres.
Clinical science (London, England : 1979) 1993;84(6):605-9.
1993: Washington C; Lance M; Davis S S
Toxicity of amphotericin B emulsion formulations.
The Journal of antimicrobial chemotherapy 1993;31(5):806-8.
1993: Price J M; Davis S S; Sparrow R A; Wilding I R
The effect of meal composition on the gastrocolonic response: implications for drug delivery to the colon.
Pharmaceutical research 1993;10(5):722-6.
1993: Barrett D A; Rutter N; Davis S S
An in vitro study of diamorphine permeation through premature human neonatal skin.
Pharmaceutical research 1993;10(4):583-7.
1993: Washington C; Koosha F; Davis S S
Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; Intralipid and Ivelip.
Journal of clinical pharmacy and therapeutics 1993;18(2):123-31.
1993: Jeffery H; Davis S S; O'Hagan D T
The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique.
Pharmaceutical research 1993;10(3):362-8.
1993: O'Hagan D T; Jeffery H; Davis S S
Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.
Vaccine 1993;11(9):965-9.
1993: Lin W; Coombes A G; Davies M C; Davis S S; Illum L
Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method.
Journal of drug targeting 1993;1(3):237-43.
1992: Wilding I R; Hardy J G; Sparrow R A; Davis S S; Daly P B; English J R
In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.
Pharmaceutical research 1992;9(11):1436-41.
1992: Fisher A N; Illum L; Davis S S; Schacht E H
Di-iodo-L-tyrosine-labelled dextrans as molecular size markers of nasal absorption in the rat.
The Journal of pharmacy and pharmacology 1992;44(7):550-4.
1992: Henry B T; Adler J; Hibberd S; Cheema M S; Davis S S; Rogers T G
Epi-fluorescence microscopy and image analysis used to measure diffusion coefficients in gel systems.
The Journal of pharmacy and pharmacology 1992;44(7):543-9.
1992: Porter C J; Moghimi S M; Illum L; Davis S S
The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow.
FEBS letters 1992;305(1):62-6.
1992: Challacombe S J; Rahman D; Jeffery H; Davis S S; O'Hagan D T
Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
Immunology 1992;76(1):164-8.
1992: Wilding I R; Davis S S; Bakhshaee M; Stevens H N; Sparrow R A; Brennan J
Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation.
Pharmaceutical research 1992;9(5):654-7.
1992: Davis S S
Delivery systems for biopharmaceuticals.
The Journal of pharmacy and pharmacology 1992;44 Suppl 1():186-90.
1992: Davis S S; Hardy J G; Newman S P; Wilding I R
Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.
European journal of nuclear medicine 1992;19(11):971-86.
1991: Wilding I R; Davis S S; Hardy J G; Robertson C S; John V A; Powell M L; Leal M; Lloyd P; Walker S M
Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers.
British journal of clinical pharmacology 1991;32(5):573-9.
1991: Coupe A J; Davis S S; Evans D F; Wilding I R
Correlation of the gastric emptying of nondisintegrating tablets with gastrointestinal motility.
Pharmaceutical research 1991;8(10):1281-5.
1991: O'Hagan D T; Jeffery H; Roberts M J; McGee J P; Davis S S
Controlled release microparticles for vaccine development.
Vaccine 1991;9(10):768-71.
1991: Elias-Jones A C; Barrett D A; Rutter N; Shaw P N; Davis S S
Diamorphine infusion in the preterm neonate.
Archives of disease in childhood 1991;66(10 Spec No):1155-7.
1991: Harper G R; Davies M C; Davis S S; Tadros T F; Taylor D C; Irving M P; Waters J A
Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro.
Biomaterials 1991;12(7):695-700.
1991: Wilding I R; Hardy J G; Davis S S; Melia C D; Evans D F; Short A H; Sparrow R A; Yeh K C
Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR).
Clinical neuropharmacology 1991;14(4):305-21.
1991: Muir I S; Moghimi S M; Illum L; Davis S S; Davies M C
The effect of block co-polymers on the uptake of model polystyrene microspheres by Kupffer cells--in vitro and in vivo studies.
Biochemical Society transactions 1991;19(3):329S.
1991: Barrett D A; Elias-Jones A C; Rutter N; Shaw P N; Davis S S
Morphine kinetics after diamorphine infusion in premature neonates.
British journal of clinical pharmacology 1991;32(1):31-7.
1991: Lamb K A; Washington C; Davis S S; Denyer S P
Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers.
The Journal of pharmacy and pharmacology 1991;43(7):522-4.
1991: O'Hagan D T; Rahman D; McGee J P; Jeffery H; Davies M C; Williams P; Davis S S; Challacombe S J
Biodegradable microparticles as controlled release antigen delivery systems.
Immunology 1991;73(2):239-42.
1991: Moghimi S M; Porter C J; Muir I S; Illum L; Davis S S
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.
Biochemical and biophysical research communications 1991;177(2):861-6.
1991: Barrett D A; Shaw P N; Davis S S
Determination of morphine and 6-acetylmorphine in plasma by high-performance liquid chromatography with fluorescence detection.
Journal of chromatography 1991;566(1):135-45.
1991: Coupe A J; Davis S S; Wilding I R
Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.
Pharmaceutical research 1991;8(3):360-4.
1991: Davis S S
Physiological factors in drug absorption.
Annals of the New York Academy of Sciences 1991;618():140-9.
1990: O'Hagan D T; Critchley H; Farraj N F; Fisher A N; Johansen B R; Davis S S; Illum L
Nasal absorption enhancers for biosynthetic human growth hormone in rats.
Pharmaceutical research 1990;7(7):772-6.
1990: Cartwright R G; Cartlidge P H; Rutter N; Melia C D; Davis S S
Transdermal delivery of theophylline to premature infants using a hydrogel disc system.
British journal of clinical pharmacology 1990;29(5):533-9.
1990: Moghimi S M; Illum L; Davis S S
Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow.
Critical reviews in therapeutic drug carrier systems 1990;7(3):187-209.
1989: Melia C D; Davis S S
Review article: mechanisms of drug release from tablets and capsules. 2. Dissolution.
Alimentary pharmacology & therapeutics 1989;3(6):513-25.
1989: Anderson M T; Harding S E; Davis S S
On the interaction in solution of a candidate mucoadhesive polymer, diethylaminoethyl-dextran, with pig gastric mucus glycoprotein.
Biochemical Society transactions 1989;17(6):1101-2.
1989: Wilding I R; Davis S S; Melia C D; Hardy J G; Evans D F; Short A H; Sparrow R A
Gastrointestinal transit of Sinemet CR in healthy volunteers.
Neurology 1989;39(11 Suppl 2):53-8.
1989: O'Hagan D T; Palin K; Davis S S; Artursson P; Sjöholm I
Microparticles as potentially orally active immunological adjuvants.
Vaccine 1989;7(5):421-4.
1989: Bentley P K; Davis S S; Johnson O L; Lowe K C; Washington C
Purification of pluronic F-68 for perfluorochemical emulsification.
The Journal of pharmacy and pharmacology 1989;41(9):661-3.
1989: Woolfrey S G; Palin K J; Davis S S
The effect of Miglycol 812 oil on the oral absorption of propranolol in the rat.
The Journal of pharmacy and pharmacology 1989;41(8):579-81.
1989: O'Hagan D T; Palin K J; Davis S S
Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization.
Vaccine 1989;7(3):213-6.
1989: Melia C D; Davis S S
Review article: mechanisms of drug release from tablets and capsules. I: Disintegration.
Alimentary pharmacology & therapeutics 1989;3(3):223-32.
1989: Koosha F; Muller R H; Davis S S
Polyhydroxybutyrate as a drug carrier.
Critical reviews in therapeutic drug carrier systems 1989;6(2):117-30.
1988: Davis S S; Washington N; Parr G D; Short A H; John V A; Lloyd P; Walker S M
Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy.
British journal of clinical pharmacology 1988;26(4):435-43.
1988: Forster D; Washington C; Davis S S
Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes.
The Journal of pharmacy and pharmacology 1988;40(5):325-8.
1988: Farraj N F; Davis S S; Parr G D; Stevens H N
The stability and solubility of progabide and its related metabolic derivatives.
Pharmaceutical research 1988;5(4):226-31.
1988: Davis S S; Norring-Christensen F; Khosla R; Feely L C
Gastric emptying of large single unit dosage forms.
The Journal of pharmacy and pharmacology 1988;40(3):205-7.
1988: Davis S S; Illum L
Polymeric microspheres as drug carriers.
Biomaterials 1988;9(1):111-5.
1988: O'Hagan D T; Palin K J; Davis S S
Intestinal absorption of proteins and macromolecules and the immunological response.
Critical reviews in therapeutic drug carrier systems 1988;4(3):197-220.
1988: Bollands A D; Lowe K C; Sharma S K; Davis S S
Biocompatibility studies with a novel perfluorochemical emulsion.
Biomaterials, artificial cells, and artificial organs 1988;16(1-3):451-3.
1988: Sharma S K; Lowe K C; Davis S S
Novel compositions of emulsified perfluorochemicals for biological uses.
Biomaterials, artificial cells, and artificial organs 1988;16(1-3):447-50.
1987: Bollands A D; Lowe K C; Sharma S K; Davis S S
Lymphoid tissue responses to a novel perfluorochemical emulsion in rats.
The Journal of pharmacy and pharmacology 1987;39(12):1021-4.
1987: Ratcliffe J H; Hunneyball I M; Wilson C G; Smith A; Davis S S
Albumin microspheres for intra-articular drug delivery: investigation of their retention in normal and arthritic knee joints of rabbits.
The Journal of pharmacy and pharmacology 1987;39(4):290-5.
1987: Farraj N F; Davis S S; Parr G D; Stevens H N
A reversed-phase high-performance liquid chromatography assay procedure for progabide and its related metabolic derivatives.
Pharmaceutical research 1987;4(1):28-32.
1987: Sharma S K; Bollands A D; Davis S S; Lowe K C
Emulsified perfluorochemicals as physiological oxygen-transport fluids: assessment of a novel formulation.
Advances in experimental medicine and biology 1987;215():97-108.
1987: Davis S S; Washington C; West P; Illum L; Liversidge G; Sternson L; Kirsh R
Lipid emulsions as drug delivery systems.
Annals of the New York Academy of Sciences 1987;507():75-88.
1986: Illum L; Thomas N W; Davis S S
Effect of a selected suppression of the reticuloendothelial system on the distribution of model carrier particles.
Journal of pharmaceutical sciences 1986;75(1):16-22.
1985: Davis S S; Hunneyball I M; Illum L; Ratcliffe J H; Smith A; Wilson C G
Recent advances in the use of microspheres for targeted therapy.
Drugs under experimental and clinical research 1985;11(9):633-40.
1984: Ratcliffe J H; Hunneyball I M; Smith A; Wilson C G; Davis S S
Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs.
The Journal of pharmacy and pharmacology 1984;36(7):431-6.

Sign-in to see more